Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local tolerability study of Zomacton administered by ZomaJet Vision X
2005-001539-31Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Aug 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of somatropin in growth hormone deficiency (GHD) and Turner syndrome (TS), sponsored by Ferring Pharmaceuticals. Started Aug 2005; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)Turner syndrome (TS)
Beyond the preview
Go deeper on 2005-001539-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001539-31.